Journals / Gaziantep Tıp Dergisi / 2012 / Cilt: 18 - Sayı: 2

Huntington koresi olan bir hastada epidural anestezi

Epidural anesthesia in a patient with Huntington's chorea

Pages
113–114
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein, we present our successful experience using epidural anesthesia in a HC patient.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Huntington's chorea (HC) is a rare, autosomal, dominant hereditary disorder of the nervous system.
📊
Key Findings & Data:Patients are at greater risk for some intraoperative complications (e.g., regurgitation and pulmonary aspiration), poor respiratory function, prolonged response to succinylcholine and thiopental, increased sensitivity to midazolam, and postoperative shivering leading to rigid spasms.
💡
Conclusion & Impact:Herein, we present our successful experience using epidural anesthesia in a HC patient.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Huntington's chorea (HC) is a rare, autosomal, dominant hereditary disorder of the nervous system. Symptoms occur in the third and fourth decade of life and manifest as involuntary choreiform movements, ataxia, and progressive mental deterioration. Only a few case reports have been published describing the anesthetic management of patients with HC. Patients are at greater risk for some intraoperative complications (e.g., regurgitation and pulmonary aspiration), poor respiratory function, prolonged response to succinylcholine and thiopental, increased sensitivity to midazolam, and postoperative shivering leading to rigid spasms. All these factors make an ideal anesthesiological management necessary for this group of patients to guarantee an absolute airway protection during all the anesthesia and a fast and safe recovery. To the best of our knowledge, epidural anesthesia in HC patients has not been reported in the literature. Herein, we present our successful experience using epidural anesthesia in a HC patient.

Özet

Huntington koresi (HK) nadir görülen otozomal dominant geçiş gösteren sinir sistemi bozukluğudur. Semptomları hayatın 3. ve 4. dekatlarında istemsiz koreiform hareketleri, ataksi ve ilerleyici mental bozulma olarak gösterir. HK tanılı olgularda anestezi yönetimi ile ilgili sadece birkaç olgu sunumu yayınlanmıştır. Hastalar bazı intraoperatif komplikasyonlar (regürjitasyon ve pulmoner aspirasyon gibi), zayıf respiratuar fonksiyon, uzamış suksinilkolin ve tiyopental cevabı, midazolama karşı yükselmiş sensitivite, ve rijit spazmlara yol açan titremeler gibi postoperatif komplikasyonlar açısından yüksek risk altındadırlar.Tüm bunlar güvenli geri dönüş ve anestezi sırasında güvenli havayolu sağlamak için ideal anestezi yönetimi gerektirmektedir. Bildiğimiz kadarıyla, literatürlerde HKli hastalarda epidural anestezi uygulanması bulunmamaktadır. Burada, HK tanılı olgumuzda başarılı epidural anestezi deneyimimizi sunmayı amaçladık.

🔖

Cite This Article

ERBAŞ, M., KARAPOLAT, B. S., DOST, B. (2022). Huntington koresi olan bir hastada epidural anestezi. Gaziantep Tıp Dergisi, Cilt: 18 - Sayı: 2, 113–114. https://ajindex.com/articles/518919

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Bloch M, Adam S, Fuller A, Kremer B, Welch JP, Wiggins S, et al. Diagnosis of Huntington disease: a model for the stages of psychological response based on experience of a predictive testing program. Am J Med Genet 1993;47(3):368-74
  2. Rodrigo MR. Huntington’s chorea: midazolam, a suitable induction agent? Br J Anaesth 1987;59(3):388-9
  3. Kaufman MA, Erb T. Propofol for patients with Huntington’s chorea? Anaesthesia 1990;45(10):889-90
  4. Nagele P, Hammerle AF. Sevoflurane and mivacurium in a patient with Huntington’s chorea. Br J Anaesth 2000;85(2):320- 1
  5. Fernandez IG, Sanchez MP, Ugalde AJ, Hernandez CM. Spinal anaesthesia in a patient with Huntington’s chorea. Anaesthesia 1997;52(4):391
  6. Gaubatz CL, Wehner RJ. Anesthetic considerations for the patient with Huntington’s disease. AANA J 1992;60(1):41-4
  7. MacPherson P, Harper I, MacDonald I. Propofol and remifentanil total intravenous anesthesia for a patient with Huntington disease. J Clin Anesth 2004;16(7):537-8
  8. Gilli E, Bartoloni A, Fiocca F, Dall'Antonia F, Carluccio S. Anaesthetic management in a case of Huntington's chorea. Minerva Anestesiol 2006;72(9):757-62
  9. Stoelting RK, Dierdorf SF, Mccammon RL. Anesthesia and coexisting disease. New York: Churchill Livingstone 1988:307
  10. Qin ZH, Wang J, Gu ZL. Development of novel therapies for Huntington’s disease: hope and challenge. Acta Pharmacol Sin 2005;26(2):129-42
  11. Kivela JE, Sprung J, Southorn PA, Watson JC, Weingarten TN. Anesthetic management of patients with Huntington disease. Anesth Analg 2010;110(2):515-23.